Functional expression of Francisella tularensis FabH and FabI, potential antibacterial targets

Protein Expression and Purification

Volumn 65, Issue 1, 2009, Pages 83-91

  Wen, Lisa ^a   Chmielowski, Jennifer N ^a   Bohn, Kelsey C ^a   Huang, Jenq Kuen ^a   Timsina, Yam N ^a   Kodali, Phanichand ^a   Pathak, Ashish K ^a  

^a WESTERN ILLINOIS UNIVERSITY   (United States)

Author keywords

Expression; FabH (3 oxoacyl acyl carrier protein synthase III); FabI (enoyl ACP reductase); Francisella tularensis

Indexed keywords

BACTERIAL PROTEIN; ENOYL ACYL CARRIER PROTEIN REDUCTASE (NADH); RECOMBINANT PROTEIN;

ARTICLE; BIOLOGICAL WARFARE AGENT; BIOSYNTHESIS; ENZYMOLOGY; FRANCISELLA TULARENSIS; GENE EXPRESSION; GENETICS; ISOLATION AND PURIFICATION;

BACTERIAL PROTEINS; BIOLOGICAL WARFARE AGENTS; ENOYL-(ACYL-CARRIER-PROTEIN) REDUCTASE (NADH); FRANCISELLA TULARENSIS; GENE EXPRESSION; RECOMBINANT PROTEINS;

BACTERIA (MICROORGANISMS); FRANCISELLA TULARENSIS; MAMMALIA;

EID: 60349111331     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2008.11.011     Document Type: Article

References (37)

1. Tärnvik A. Nature of protective immunity to Francisella tularensis. Rev. of Infect. Dis. 11 (1989) 440-451
2. Dennis D.T., Inglesby T.V., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., Fine A.D., Friedlander A.M., Hauer J., Layton M., Lillibridge S.R., McDade J.E., Osterholm M.T., O'Toole T., Parker G., Perl T.M., Russell P.K., and Tonat K. Tularemia as a biological weapon, medical and public health management. J. Am. Med. Assoc. 285 (2001) 2763-2773
3. Jortani S.A., Snyder J.W., and Valdes Jr. R. The role of the clinical laboratory in managing chemical or biological terrorism. Clin. Chem. 46 (2000) 1883-1893
4. Heath R.J., White S.W., and Rock C.O. Lipid biosynthesis as a target for antibacterial agents. Prog. Lipid Res. 40 (2001) 467-497
5. Campbell J.W., and Cronan J.E.J. Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery. Annu. Rev. Microbiol. 55 (2001) 305-332
6. Zhang Y.-M., White S.W., and Rock C.O. Inhibiting bacterial fatty acid synthesis. J. Biol. Chem. 281 (2006) 17541-17544
7. Lai C.-Y., and Cronan J.E. β-Ketoacyl-acyl carrier protein synthase III (FabH) is essential for bacterial fatty acid synthesis. J. Biol. Chem. 278 (2003) 51494-51503
8. Heath R.J., and Rock C.O. Regulation of fatty acid elongation and initiation by acyl-acyl carrier protein in Escherichia coli. J. Biol. Chem. 271 (1996) 1833-1836
9. Lu H., and Tonge P.J. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway. Acc. Chem. Res. 41 (2008) 11-20
10. Chung C.T., Niemela S.L., and Miller R.H. One-step preparation of competent Escherichia coli: transformation and storage of bacterial cells in the same solution. Proc. Nat. Acad. Sci. USA 86 (1989) 2172-2175
11. Heath R.J., and Rock C.O. Inhibition of beta-ketoacyl-acyl carrier protein synthase III (FabH) by acyl-acyl carrier protein in Escherichia coli. J. Biol. Chem. 271 (1996) 10996-11000
12. Zhang Y.-M., and Rock C.O. Evaluation of epigallocatechin gallate and related plant polyphenols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase. J. Biol. Chem. 279 (2004) 30994-31001
13. Larsson P., Oyston P., Chain P., Chu M., Duffield M., Fuxelius H., Garcia E., Hälltorp G., Johansson D., Isherwood K., Karp P., Larsson E., Liu Y., Michell S., Prior J., Prior R., Malfatti S., Sjöstedt A., Svensson K., Thompson N., Vergez L., Wagg J., Wren B., Lindler L., Andersson S., Forsman M., and Titball R. The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nat. Genet. 37 (2005) 153-159
14. Chaudhuri R.R., Ren C.-P., Desmond L., Vincent G.A., Silman N.J., Brehm J.K., Elmore M.J., Hudson M.J., Forsman M., Isherwood K.E., Guryčová D., Minton N.P., Titball R.W., Pallen M.J., and Vipond R. Genome sequencing shows that European isolates of Francisella tularensis subspecies tularensis are almost identical to US Laboratory Strain Schu S4. PLoS ONE 2 (2007) e352
15. Petrosino J.F., Xiang Q., Karpathy S.E., Jiang H., Yerrapragada S., Liu Y., Gioia J., Hemphill L., Gonzalez A., Raghavan T.M., Uzman A., Fox G.E., Highlander S., Reichard M., Morton R.J., Clinkenbeard K.D., and Weinstock G.M. Chromosome rearrangement and diversification of Francisella tularensis revealed by the type B (OSU18) genome sequence. J. Bacteriol. 188 (2006) 6977-6985
16. Beckstrom-Sternberg S.M., Auerbach R.K., Godbole S., Pearson J.V., Beckstrom-Sternberg J.S., Deng Z., Munk C., Kubota K., Zhou Y., Bruce D., Noronha J., Scheuermann R.H., Wang A., Wei X., Wang J., Hao J., Wagner D.M., Brettin T.S., Brown N., Gilna P., and Keim P.S. Complete genomic characterization of a pathogenic A.II strain of Francisella tularensis subspecies tularensis. PLoS ONE 2 (2007) e947
17. Qiu X., Janson C.A., Konstantinidis A.K., Nwagwu S., Silverman C., Smith W.W., Khandekar S., Lonsdale J., and Abdel-Meguid S.S. Crystal structure of beta-ketoacyl-acyl carrier protein synthase III. A key condensing enzyme in bacterial fatty acid biosynthesis. J. Biol. Chem. 274 (1999) 36465-36471
18. Davies C., Heath R.J., White S.W., and Rock C.O. The 1.8 Å crystal structure and active-site architecture of β-ketoacyl-acyl carrier protein synthase III (FabH) from Escherichia coli. Structure 8 (2000) 185-195
19. Qiu X., Choudhry A.E., Janson C.A., Grooms M., Daines R.A., Lonsdale J.T., and Khandekar S.S. Crystal structure and substrate specificity of the {beta}-ketoacyl-acyl carrier protein synthase III (FabH) from Staphylococcus aureus. Protein Sci. 14 (2005) 2087-2094
20. Sachdeva S., Musayev F.N., Alhamadsheh M.M., Scarsdale J.N., Wright H.T., and Reynolds K.A. Separate entrance and exit portals for ligand traffic in Mycobacterium tuberculosis FabH. Chem. Biol. 15 (2008) 402-412
21. Pidugu L.S., Kapoor M., Surolia N., Surolia A., and Suguna K. Structural basis for the variation in triclosan affinity to enoyl reductases. J. Mol. Biol. 343 (2004) 147-155
22. Rafi S., Novichenok P., Kolappan S., Zhang X., Stratton C.F., Rawat R., Kisker C., Simmerling C., and Tonge P.J. Structure of acyl carrier protein bound to FabI, the FASII enoyl reductase from Escherichia coli. J. Biol. Chem. 281 (2006) 39285-39293
23. Heerding D.A., Chan G., DeWolf W.E., Fosberry A.P., Janson C.A., Jaworski D.D., McManus E., Miller W.H., Moore T.D., Payne D.J., Qiu X., Rittenhouse S.F., Slater-Radosti C., Smith W., Takata D.T., Vaidya K.S., Yuan C.C.K., and Huffman W.F. 1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI). Bioorg. & Med. Chem. Lett. 11 (2001) 2061-2065
24. Qiu X., Janson C.A., Court R.I., Smyth M.G., Payne D.J., and Abdel-Meguid S.S. Molecular basis for triclosan activity involves a flipping loop in the active site. Protein Sci. 8 (1999) 2529-2532
25. Ward W.H.J., Holdgate G.A., Rowsell S., McLean E.G., Pauptit R.A., Clayton E., Nichols W.W., Colls J.G., Minshull C.A., Jude D.A., Mistry A., Timms D., Camble R., Hales N.J., Britton C.J., and Taylor I.W.F. Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan. Biochemistry 38 (1999) 12514-12525
26. Baldock C., Rafferty J.B., Sedelnikova S.E., Baker P.J., Stuitje A.R., Slabas A.R., Hawkes T.R., and Rice D.W. A mechanism of drug action revealed by structural studies of enoyl reductase. Science 274 (1996) 2107-2110
27. Seefeld M.A., Miller W.H., Newlander K.A., Burgess W.J., DeWolf W.E., Elkins P.A., Head M.S., Jakas D.R., Janson C.A., Keller P.M., Manley P.J., Moore T.D., Payne D.J., Pearson S., Polizzi B.J., Qiu X., Rittenhouse S.F., Uzinskas I.N., Wallis N.G., and Huffman W.F. Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK. J. Med. Chem. 46 (2003) 1627-1635
28. Perozzo R., Kuo M., Sidhu A.b.S., Valiyaveettil J.T., Bittman R., Jacobs Jr. W.R., Fidock D.A., and Sacchettini J.C. Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase. J. Biol. Chem. 277 (2002) 13106-13114
29. Freundlich J.S., Wang F., Tsai H.-C., Kuo M., Shieh H.-M., Anderson J.W., Nkrumah L.J., Valderramos J.-C., Yu M., Kumar T.R.S., Valderramos S.G., Jacobs Jr. W.R., Schiehser G.A., Jacobus D.P., Fidock D.A., and Sacchettini J.C. X-ray structural analysis of Plasmodium falciparum enoyl acyl carrier protein reductase as a pathway toward the optimization of triclosan antimalarial efficacy. J. Biol. Chem. 282 (2007) 25436-25444
30. Muench S.P., Prigge S.T., McLeod R., Rafferty J.B., Kirisits M.J., Roberts C.W., Mui E.J., and Rice D.W. Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents. Acta Crystallogr., Sect. D: Biol. Crystallogr. 63 (2007) 328-338
31. Dias M.V.B., Vasconcelos I.B., Prado A.M.X., Fadel V., Basso L.A., de Azevedo W.F., and Santos Jr. D.S. Crystallographic studies on the binding of isonicotinyl-NAD adduct to wild-type and isoniazid resistant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis. J. Struct. Biol. 159 (2007) 369-380
32. Hyung Ho Lee J.M.S.W.S. Crystal structure of the Helicobacter pylori enoyl-acyl carrier protein reductase in complex with hydroxydiphenyl ether compounds, triclosan and diclosan. Proteins: Structure, Function, and Bioinformatics 69 (2007) 691-694
33. Oefner C., Schulz H., D'Arcy A., and Dale G.E. Mapping the active site of Escherichia coli malonyl-CoA-acyl carrier protein transacylase (FabD) by protein crystallography. Acta Crystallogr., Sect. D: Biol. Crystallogr. D 62 (2006) 613-618
34. Li Z., Huang Y., Ge J., Fan H., Zhou X., Li S., Bartlam M., Wang H., and Rao Z. The crystal structure of MCAT from Mycobacterium tuberculosis reveals three new catalytic models. J. Mol. Biol. 371 (2007) 1075-1083
35. Jantzen E., Berdal B.P., and Omland T. Cellular fatty acid composition of Francisella tularensis. J. Clin. Microbiol. 10 (1979) 928-930
36. Nichols P.D., Mayberry W.R., Antworth C.P., and White D.C. Determination of monounsaturated double-bond position and geometry in the cellular fatty acids of the pathogenic bacterium Francisella tularensis. J. Clin. Microbiol. 21 (1985) 738-740
37. Daines R.A., Pendrak I., Sham K., Van Aller G.S., Konstantinidis A.K., Lonsdale J.T., Janson C.A., Qiu X., Brandt M., Khandekar S.S., Silverman C., and Head M.S. First X-ray cocrystal structure of a bacterial FabH condensing enzyme and a small molecule inhibitor achieved using rational design and homology modeling. J. Med. Chem. 46 (2003) 5-8